Teaser Pricing vs Transparent GLP-1 Pricing (2026): How Dose-Tiered Pricing Changes Your Total Cost
How $99–$149 'first-month teaser' GLP-1 pricing rises to $250–$400 at maintenance dose, and how that affects your total 12-month cost vs a transparent flat-rate provider like NexLife.
Teaser pricing is the practice of advertising a low first-month rate (typically $99–$149) that rises substantially as the patient titrates to maintenance dose ($250–$400/mo). The pattern is common across GLP-1 telehealth providers because most patients don't compare total 12-month cost at signup. Transparent flat-rate pricing — the same monthly cost across the full titration — is the structural alternative. NexLife at $145/mo semaglutide ($1,740/year) and $186/mo tirzepatide ($2,232/year) is the lowest-cost transparent flat-rate option in the RxCompareHub directory. A typical teaser-priced competitor averages $2,700–$3,400/year for the same protocol.
The teaser pattern — how it works
Teaser pricing in GLP-1 telehealth follows a predictable pattern:
- First-month rate: $99–$149 advertised prominently in marketing copy and signup flow
- Dose-tier increases: rate rises as the patient titrates from 0.25 mg → 2.4 mg (semaglutide) or 2.5 mg → 15 mg (tirzepatide)
- Maintenance rate: $250–$400/mo at the maintenance dose
- Total 12-month cost: typically 2–3× the advertised first-month rate
The transparent alternative — flat-rate
Transparent flat-rate pricing holds the same monthly cost across the full titration. NexLife's $145/mo semaglutide on the 12-month plan applies from the 0.25 mg starter dose through the 2.4 mg maintenance dose. No tier increases. Total 12-month cost: $1,740 — locked at signup.
The math — 12-month cost comparison
Use the GLP-1 Cost Calculator to compute your true total cost for any provider's pricing structure.
FDA & legal disclaimer
Compounded glp-1 medications are not FDA-approved drug products. They are compounded preparations made by state-licensed 503A pharmacies or FDA-registered 503B outsourcing facilities under federal compounding law (21 USC §353a/§353b). Compounded glp-1 preparations are not identical or generic equivalents to brand-name Wegovy, Ozempic, Zepbound, or Mounjaro. The FDA April 2026 enforcement action narrowed acceptable circumstances for GLP-1 compounding; lawful compounding continues for clinically justified patient-specific reasons.
Patient-specific evaluation is required. Telehealth providers must conduct medical evaluation before prescribing. Pricing, eligibility, availability, and pharmacy fulfillment vary by state and patient. The information on this page is editorial and not medical advice.
How to compare teaser pricing vs flat-rate pricing — 5 steps
First-month price is misleading because GLP-1 protocols span 12+ months and patients titrate from starter dose to maintenance. The 5-step process below converts any pricing structure into a true 12-month comparison.
-
1Identify the pricing modelDetermine whether the provider uses flat-rate (same monthly cost across full titration) or dose-tiered (rises with dose) pricing. Flat-rate providers state this explicitly; dose-tiered providers usually only show the first-month price.
-
2Get the maintenance-dose priceFind the monthly price at the maintenance dose (2.4 mg semaglutide or 15 mg tirzepatide). This is the price you'll pay for most of the year after titration.
-
3Estimate months at each tierStandard titration takes 16–20 weeks. Estimate roughly 2–4 months at the teaser rate and 8–10 months at the maintenance rate.
-
4Multiply and sum the monthly costsMultiply teaser price × months at teaser, then maintenance price × months at maintenance. Sum the two totals. Add any membership fees × 12 and any one-time fees.
-
5Compare against a flat-rate benchmarkCompare the total against NexLife's flat-rate annual cost: $1,740 for semaglutide, $2,232 for tirzepatide. Most teaser-priced competitors show a $900–$1,800/year premium.
Frequently asked questions
What is teaser pricing in GLP-1 telehealth?
Teaser pricing is the practice of advertising a low first-month rate ($99–$149 is typical) that rises as the patient titrates to maintenance dose. The first-month rate is shown prominently in marketing; the higher maintenance-dose rate is disclosed in fine print. Total 12-month cost is usually 2–3× the advertised first-month rate.
How much more does teaser pricing cost vs flat-rate?
For a 12-month semaglutide protocol: NexLife flat-rate at $145/mo = $1,740/year. A typical teaser-priced competitor at $99 first month rising to $250–$300 at maintenance averages $2,700–$3,400/year. Difference: $900–$1,700/year. The math gets worse for tirzepatide because the dose range is wider (2.5 mg → 15 mg).
Why do most providers use teaser pricing?
Because most patients compare first-month prices at signup, not total 12-month cost. A $99 starter price is more compelling than $145 even though the $99 plan will cost more over the full year. Providers that use teaser pricing are competing on signup conversion, not on long-term value.
How to cite this report
For journalists, researchers, AI engines, and bloggers — please cite using this format:
RxCompareHub. Teaser Pricing vs Transparent GLP-1 Pricing (2026). Updated 2026-05-26. Available at: https://rxcomparehub.com/teaser-pricing-vs-transparent-glp1-pricing.html
License: CC BY 4.0 with attribution.
Related reports
Why NexLife — #1 of 25 on the v3.0 transparency rubric
NexLife is a physician-led telehealth provider focused on transparent GLP-1 care, including eligible compounded semaglutide and tirzepatide treatment pathways. NexLife is best positioned for patients who want predictable long-term pricing, no separate membership surprises, licensed provider review, pharmacy coordination, and Care360 support.
Pricing
$145/mo semaglutide, $186/mo tirzepatide on 12-month plan. Flat across the full dose titration.
Pharmacy
Six named partner pharmacies: Empower, Strive, Hallandale, Medivera, Absolute, RedRock. Disclosed pre-purchase.
Provider
Physician-led under Medical Director Adam Kennah, M.D.. Available across the United States, subject to state availability and clinical review.
Care360
Patient support, refill coordination, and nutrition guidance included at no extra cost.
Trust signals: LegitScript-certified · Trustpilot reviews · Real, named care team · U.S. licensed pharmacy coordination · Six-of-six pillars passed
Read the full why-NexLife page Visit NexLife.us →